Driving impairment and altered ocular activity under the effects of alprazolam and alcohol: A randomized, double-blind, placebo-controlled study

被引:2
|
作者
Aitken, Blair [1 ]
Hayley, Amie C. [1 ,2 ]
Ford, Talitha C. [1 ,3 ]
Geier, Lauren [4 ]
Shiferaw, Brook A. [1 ,2 ,5 ]
Downey, Luke A. [1 ,2 ,6 ]
机构
[1] Swinburne Univ Technol, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia
[2] Austin Hlth, Inst Breathing & Sleep IBAS, Heidelberg, Vic, Australia
[3] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia
[4] Forens Sci South Australia, Adelaide, Australia
[5] Seeing Machines, Canberra, ACT 2612, Australia
[6] Swinburne Univ Technol, Ctr Mental Hlth & Brain Sci, Hawthorn, Vic 3122, Australia
基金
英国医学研究理事会;
关键词
Alcohol; Alprazolam; Driving; Gaze entropy; Ocular monitoring; Road safety; PERFORMANCE; PREVALENCE; RISK; BENZODIAZEPINES; RESPONSIBILITY; PSYCHOMOTOR; DRUGS;
D O I
10.1016/j.drugalcdep.2023.110919
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Alprazolam, also known by trade-name Xanax, is regularly detected along with alcohol in blood samples of drivers injured or killed in traffic collisions. While their co-consumption is principally legal, policy guidelines concerning fitness-to-drive are lacking and methods to index impairment are underdeveloped. Methods: In this randomized, double-blind, placebo-controlled, crossover trial, we examined whether legally permissible levels of alcohol [target 0.04% blood alcohol concentration (BAC)], alprazolam (1 mg), and their combination impacts driving performance, and whether driving impairment can be indexed by ocular activity. Participants completed a test battery consisting of a 40-minute simulated highway drive with ocular parameters assessed simultaneously, the Karolinska Sleepiness Scale, and a confidence to drive assessment following four separate treatment combinations. The predictive efficacy of ocular parameters to identify alcohol and alprazolam-related driving impairment was also examined.Results: Among 21 healthy, fully licensed drivers (37% female, mean age 28.43, SD & PLUSMN; 3.96), driving performance was significantly impacted by alprazolam, alcohol, and their combination. Linear regression models revealed that the odds of an out-of-lane event occurring increased five-fold under the influence alprazolam alone and when combined with alcohol. An increase in gaze transition entropy (GTE) demonstrated the strongest association with the odds of an out-of-lane event occurring in the same minute, with both microsleeps and fixation rate achieving moderate accuracy across treatments.Conclusions: Alprazolam and alcohol, alone and in combination, impaired select aspects of vehicle control over time. GTE, microsleeps, and fixation rate show potential as real-time indicators of driving impairment and crash risk associated with alcohol and alprazolam consumption.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] SIAXI Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea
    Jost, Wolfgang H.
    Friedman, Andrzej
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Pagan, Fernando
    Flatau-Baque, Birgit
    Csikos, Janos
    Cairney, Claire J.
    Blitzer, Andrew
    NEUROLOGY, 2019, 92 (17) : E1982 - E1991
  • [12] Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke
    Cramer, Steven C.
    Dobkin, Bruce H.
    Noser, Elizabeth A.
    Rodriguez, Rachelle W.
    Enney, Lori A.
    STROKE, 2009, 40 (09) : 3034 - 3038
  • [13] Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Chigurupati, Harsha
    Auddy, Biswajit
    Biyani, M.
    Stohs, Sidney J.
    PHYTOTHERAPY RESEARCH, 2016, 30 (12) : 1943 - 1953
  • [14] A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence
    Brown, E. Sherwood
    Carmody, Thomas J.
    Schmitz, Joy M.
    Caetano, Raul
    Adinoff, Bryon
    Swann, Alan C.
    Rush, A. John
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (11) : 1863 - 1869
  • [15] Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study
    Stenberg, Jan-Henry
    Terevnikov, Viatcheslav
    Joffe, Marina
    Tiihonen, Jari
    Tchoukhine, Evgueni
    Burkin, Mark
    Joffe, Grigori
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (04) : 433 - 441
  • [16] Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
    Kraglund, Kristian Lundsgaard
    Mortensen, Janne Kaergaard
    Johnsen, Soren Paaske
    Andersen, Grethe
    Grove, Erik Lerkevang
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [17] New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide
    Gunal, DI
    Afsar, N
    Bekiroglu, N
    Aktan, S
    NEUROLOGICAL SCIENCES, 2000, 21 (05) : 315 - 317
  • [18] New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide
    D.İ Gunal
    N. Afşar
    N. Bekiroglu
    S. Aktan
    Neurological Sciences, 2000, 21 : 315 - 317
  • [19] Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
    Polymeropoulos, Vasilios M.
    Czeisler, Mark E.
    Gibson, Mary M.
    Anderson, Austin A.
    Miglo, Jane
    Wang, Jingyuan
    Xiao, Changfu
    Polymeropoulos, Christos M.
    Birznieks, Gunther
    Polymeropoulos, Mihael H.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [20] Effects of Rapid Recovery on Alcohol Hangover Severity: A Double-Blind, Placebo-Controlled, Randomized, Balanced Crossover Trial
    Scholey, Andrew
    Ayre, Elizabeth
    Stock, Ann-Kathrin
    Verster, Joris C.
    Benson, Sarah
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 12